Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer

Eylem Kulkoyluoglu, Zeynep Madak-Erdogan

Research output: Contribution to journalReview articlepeer-review

Abstract

Estrogens regulate function of reproductive and non-reproductive tissues in healthy and diseased states including breast cancer. They mainly work through estrogen receptor alpha (ERα) and/or estrogen receptor beta (ERβ). There are various ERα targeting agents that have been used for treatment of ER (+) breast tumors. The impact of direct nuclear activity of ER is very well characterized in ER (+) breast cancers and development and progression of endocrine resistance. Recent studies also suggested important roles for extranuclear-initiated ERα pathways, which would decrease the potency and efficiency of ERα targeting agents. In this mini-review, we will discuss the role of nuclear and extra-nuclear ER signaling and how they relate to therapy resistance in breast cancer.

Original languageEnglish (US)
Pages (from-to)41-47
Number of pages7
JournalSteroids
Volume114
DOIs
StatePublished - 2016

Keywords

  • Breast cancer
  • Estrogen receptor
  • Kinase signaling
  • Tamoxifen resistance

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology
  • Pharmacology
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer'. Together they form a unique fingerprint.

Cite this